1071 related articles for article (PubMed ID: 19702031)
21. Management of psoriasis with calcipotriol used as monotherapy.
Ramsay CA
J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S53-4. PubMed ID: 9344185
[TBL] [Abstract][Full Text] [Related]
22. Intra-individual comparison of the cutaneous safety and efficacy of calcitriol 3 microg g(-1) ointment and calcipotriol 50 microg g(-1) ointment on chronic plaque psoriasis localized in facial, hairline, retroauricular or flexural areas.
Ortonne JP; Humbert P; Nicolas JF; Tsankov N; Tonev SD; Janin A; Czernielewski J; Lahfa M; Dubertret L
Br J Dermatol; 2003 Feb; 148(2):326-33. PubMed ID: 12588387
[TBL] [Abstract][Full Text] [Related]
23. Calcitriol ointment: a review of a topical vitamin D analog for psoriasis.
Sigmon JR; Yentzer BA; Feldman SR
J Dermatolog Treat; 2009; 20(4):208-12. PubMed ID: 19444692
[TBL] [Abstract][Full Text] [Related]
24. Clinical assessment of patients with recalcitrant psoriasis in a randomized, observer-blind, vehicle-controlled trial using indigo naturalis.
Lin YK; Chang CJ; Chang YC; Wong WR; Chang SC; Pang JH
Arch Dermatol; 2008 Nov; 144(11):1457-64. PubMed ID: 19015420
[TBL] [Abstract][Full Text] [Related]
25. Calcipotriol. A new topical antipsoriatic.
Kragballe K; Iversen L
Dermatol Clin; 1993 Jan; 11(1):137-41. PubMed ID: 8435908
[TBL] [Abstract][Full Text] [Related]
26. Calcitriol (Vectical) for mild to moderate plaque psoriasis.
Med Lett Drugs Ther; 2009 Sep; 51(1320):70-1. PubMed ID: 19738550
[TBL] [Abstract][Full Text] [Related]
27. A randomized, multicenter study of calcipotriene ointment and clobetasol propionate foam in the sequential treatment of localized plaque-type psoriasis: short- and long-term outcomes.
Koo J; Blum RR; Lebwohl M
J Am Acad Dermatol; 2006 Oct; 55(4):637-41. PubMed ID: 17010744
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of topical treatment in psoriasis with MC903, a new vitamin D analogue.
Staberg B; Roed-Petersen J; Menné T
Acta Derm Venereol; 1989; 69(2):147-50. PubMed ID: 2564233
[TBL] [Abstract][Full Text] [Related]
29. Safety and efficacy of calcipotriol ointment (Dovonex) in treating children with psoriasis vulgaris.
Darley CR; Cunliffe WJ; Green CM; Hutchinson PE; Klaber MR; Downes N
Br J Dermatol; 1996 Sep; 135(3):390-3. PubMed ID: 8949431
[TBL] [Abstract][Full Text] [Related]
30. Topical calcipotriol (MC 903) for psoriasis: a clinical study.
Mozzanica N; Cattaneo A; Schmitt E; Legori A; Finzi AF
Acta Derm Venereol Suppl (Stockh); 1994; 186():169-70. PubMed ID: 8073826
[TBL] [Abstract][Full Text] [Related]
31. Efficacy, tolerability, and safety of calcipotriol ointment in disorders of keratinization. Results of a randomized, double-blind, vehicle-controlled, right/left comparative study.
Kragballe K; Steijlen PM; Ibsen HH; van de Kerkhof PC; Esmann J; Sorensen LH; Axelsen MB
Arch Dermatol; 1995 May; 131(5):556-60. PubMed ID: 7741542
[TBL] [Abstract][Full Text] [Related]
32. The efficacy and safety of topically applied indigo naturalis ointment in patients with plaque-type psoriasis.
Lin YK; Wong WR; Chang YC; Chang CJ; Tsay PK; Chang SC; Pang JH
Dermatology; 2007; 214(2):155-61. PubMed ID: 17341866
[TBL] [Abstract][Full Text] [Related]
33. Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis.
Menter A; Abramovits W; Colón LE; Johnson LA; Gottschalk RW
J Drugs Dermatol; 2009 Jan; 8(1):52-7. PubMed ID: 19180896
[TBL] [Abstract][Full Text] [Related]
34. Long-term safety and efficacy of high-concentration (20 microg/g) tacalcitol ointment in psoriasis vulgaris.
Miyachi Y; Ohkawara A; Ohkido M; Harada S; Tamaki K; Nakagawa H; Hori Y; Nishiyama S
Eur J Dermatol; 2002; 12(5):463-8. PubMed ID: 12370136
[TBL] [Abstract][Full Text] [Related]
35. Combined topical calcipotriene ointment 0.005% and various systemic therapies in the treatment of plaque-type psoriasis vulgaris: review of the literature and results of a survey sent to 100 dermatologists.
Katz HI
J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S62-8. PubMed ID: 9344188
[TBL] [Abstract][Full Text] [Related]
36. A double-blind, randomized quantitative comparison of calcitriol ointment and calcipotriol ointment on epidermal cell populations, proliferation and differentiation.
Körver JE; Vissers WH; van Rens DW; Pasch MC; van Erp PE; Boezeman JB; van De Kerkhof PC
Br J Dermatol; 2007 Jan; 156(1):130-7. PubMed ID: 17199579
[TBL] [Abstract][Full Text] [Related]
37. The role of topical vitamin D modulators in psoriasis therapy.
Tanghetti EA
J Drugs Dermatol; 2009 Aug; 8(8 Suppl):s4-8. PubMed ID: 19702030
[TBL] [Abstract][Full Text] [Related]
38. Tacalcitol ointment in the treatment of psoriasis vulgaris: a multicentre, placebo-controlled, double-blind study on efficacy and safety.
Van de Kerkhof PC; Werfel T; Haustein UF; Luger T; Czarnetzki BM; Niemann R; Plänitz-Stenzel V
Br J Dermatol; 1996 Nov; 135(5):758-65. PubMed ID: 8977677
[TBL] [Abstract][Full Text] [Related]
39. The effects of UVB plus calcipotriol on systemic calcium homeostasis in patients with chronic plaque psoriasis.
Bourke JF; Iqbal SJ; Hutchinson PE
Clin Exp Dermatol; 1997 Nov; 22(6):259-61. PubMed ID: 9604449
[TBL] [Abstract][Full Text] [Related]
40. [Topical corticosteroids and corticosteroid sparing therapy in psoriasis management].
Sukarovska BG; Lipozencić J; Vrzogić P
Acta Med Croatica; 2007 Sep; 61(4):375-81. PubMed ID: 18044472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
